Purchase Order 75N95020P00162
Award Date 4/15/20
Potential Completion Date 10/31/20
Potential Value $62K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Shelton, CT 06484, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health (NIH) Clinical Center awarded a $101,599.04 firm fixed-price purchase order to Revvity Health Sciences, Inc. to provide COVID-19 related equipment and reagents. The award has a Coronavirus COVID-19 National Interest Action Code and was completed on April 10, 2020, shortly after the initial contract award on April 6, 2020. No set-aside designation was used for this award. Revvity Health Sciences, Inc. is a for-profit...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed-price purchase order to Revvity Health Sciences, Inc. for $20,685.50. The contract calls for Revvity to deliver 10,000 test kits of its proprietary Revvity HTRF SARS-CoV-2 capsid kit to the agency's specified delivery location in Rockville, Maryland by March 31, 2024. The solicitation sought this specific kit, which uses a homogeneous...
- This firm fixed price purchase order was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Revvity Health Sciences, Inc. for $1,276,403.77. The contract calls for the delivery of an Opera Phenix High Content Screening Imager and associated parts from manufacturer PerkinElmer. This equipment will be used by NCATS' Emerging Technologies Branch BSL3 Laboratory to screen potential drugs against SARS-CoV-2, the virus that causes COVID-19, in...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $180,772.01 firm-fixed-price purchase order to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services. The contract, which does not have a set-aside designation, is for the purchase of a CHEMAGIC 360 device to support the agency's Coronavirus COVID-19 response efforts. Revvity Health Sciences, Inc. is a subsidiary of Revvity Inc., which has previously...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed price purchase order to Revvity Health Sciences, Inc. for the purchase of two reagent kits: the HTRF cAMP Gi Assay kit and the HTRF cAMP Gs Dynamic Assay kit. The total potential value of the award is $243,665.00. These kits will be used by NCATS' Tox21 group to screen a library of 10,000 compounds as part of a cross-partner project...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order to Revvity Health Sciences, Inc. for a GENE ASSAY SYSTEM 1000ML with a potential value of $13,959.00. The contract has a completion date of September 28, 2018. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and services that has received numerous prime contracts and subcontracts from...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Revvity Health Sciences, Inc. for a Steadylite Plus Reporter Gene Assay Reagent System. The $23,209.50 contract does not have a set-aside designation. Revvity Health Sciences is a for-profit manufacturer that has provided a variety of medical devices and equipment, including automation systems for genetic...
- The National Center for Advancing Translational Sciences (NCATS) awarded a firm fixed-price purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on April 11, 2025, for HTRF MAB Anti 6HIS-TB and Streptavidin-XLent reagents totaling 20,000 points, with a contract ceiling value of $12,440.16. The contract will be completed by April 6, 2026, with performance taking place in Hopkinton, Massachusetts. This procurement does not utilize a small business set-aside...
- This is a Firm Fixed Price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Revvity Health Sciences, Inc. on May 15, 2019 for a Reporter Gene Assay System. The potential value of this contract is $23,891.30 with a completion date of May 5, 2020. The place of performance is Shelton, CT. This award does not appear to have a set-aside designation. Revvity Health Sciences, Inc. is a...
- This federal contract award to Revvity Health Sciences, Inc. is a firm fixed-price Purchase Order valued at $20,246.40 with the Centers for Disease Control and Prevention (CDC) for laboratory equipment and services. The award has a period of performance through March 24, 2023. Revvity Health Sciences, Inc. is a subsidiary of the parent company Revvity Inc., which provides medical imaging products and services to federal agencies through prime contracts and subcontracts. This award does not...